Thin melanoma and late recurrences: it is never too thin and never too late

By Richetta Antonio   Bottoni Ugo   Paolino Giovanni   Clerico Rita   Cantisani Carmen   Ambrifi Marina   Corsetti Paola   Calvieri Stefano  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-3

Humana Press, Inc

Access to resources Recommend Favorite

Paclitaxel in Advanced Ovarian Cancer: Too Much Optimism?

By Bulusu V.R.   Allerton R.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 335-335

Elsevier

Access to resources Recommend Favorite

Tumour escape: antitumour effectors too much of a good thing?

By Pawelec Graham  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 262-274

Springer Publishing Company

Access to resources Recommend Favorite

Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature

By Mook Stella  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1406-1413

Springer Publishing Company

Access to resources Recommend Favorite

Melanin as a potential target for radionuclide therapy of metastatic melanoma

By Dadachova Ekaterina   Casadevall Arturo  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 541-549

Future Medicine

Access to resources Recommend Favorite